[Role of electrophysiology in the prognosis and therapy of cardiomyopathies]

G Ital Cardiol. 1999 Oct;29(10):1190-4.

[Article in Italian]

Authors

F Laurenzi¹, A Avella, E Adinolfi, P Dini

Affiliation

¹ Modulo Dipartimentale di Elettrost molazione, Elettrofisiologia e Aritmologia Ospedale S. Camillo, Roma.

PMID: 10546132

No abstract available

Publication types

Comparative Study

MeSH terms

Adrenergic beta-Antagonists / therapeutic use
Amiodarone / therapeutic use
Anti-Arrhythmia Agents / therapeutic use
Arrhythmias, Cardiac / drug therapy
Arrhythmias, Cardiac / prevention & control
Arrhythmias, Cardiac / therapy
Cardiomyopathies / diagnosis*
Cardiomyopathies / mortality
Cardiomyopathies / physiopathology
Cardiomyopathies / therapy*
Clinical Trials as Topic
Defibrillators, Implantable
Electrophysiology
Female
Follow-Up Studies
Hemodynamics
Humans
Male
Meta-Analysis as Topic
Myocardial Infarction / etiology
Myocardial Infarction / prevention & control
Primary Prevention
Prognosis
Randomized Controlled Trials as Topic
Risk Factors
Sotalol / therapeutic use
Time Factors
Vasodilator Agents / therapeutic use

Substances

Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Vasodilator Agents
Sotalol
Amiodarone